June 22, 2026 Elevar Therapeutics Announces First Patients Dosed in Phase 2 Study of Lirafugratinib Among Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement
June 22, 2026 IBM and OpenAI Bring Frontier AI to Cyber Defense–Helping Enterprises Keep Pace with Machine-Speed Threats
June 22, 2026 FMC Corporation announces date for second quarter 2026 earnings release and webcast conference call